Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103854
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103854
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103854
Figure 1 The changes in healthy livers, livers at different stages of diseases, and local liver cells, as well as the changes in some gut microbiota in the pathological states of the liver at various stages.
MASLD: Metabolic dysfunction-associated steatotic liver disease; MAFL: Metabolic dysfunction-associated fatty liver; MASH: Metabolic dysfunction-associated steatohepatitis. Created from BIOGDP.com[93].
- Citation: Shu JZ, Huang YH, He XH, Liu FY, Liang QQ, Yong XT, Xie YF. Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression. World J Hepatol 2025; 17(3): 103854
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/103854.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.103854